Covid-19 Medicine Isn’t As Effective As It Used To Be For Patients With Weak Immune Systems
According to new reports, the effect of Evusheld, a commonly used monoclonal antibody therapy against Covid-19 is becoming weak to resist the new omicron strains that have sprung up in the US. As of last week, a lot of new Covid infections were reported and these were caused by the new strains that resisted the…